|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/40428406/ Glycogen storage disease Review Genes (Basel). 2025 May 15;16(5):584. Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance Egidio Candela 1 2, Giulia Montanari 3, Andrea Zanaroli 3, Federico Baronio 1, Rita Ortolano 1, Giacomo Biasucci 4 5, Marcello Lanari 1 2 PMCID: PMC12111550 DOI: 10.3390/genes16050584 Published on:
Mar-2025
|
https://pubmed.ncbi.nlm.nih.gov/40384510/ Hepatitis J Pediatr Gastroenterol Nutr. 2025 May 19. Severe hepatitis in pediatric patients: The Severe Hepatitis In Pediatric Patients (SHIPP) registry Mohit Kehar 1, Katherine Black 2, Christopher Chu 3, Rohit Kohli 4, Saeed Mohammad 5; SHIPP study group DOI: 10.1002/jpn3.70083 Abstract Published on:
May-2025
|
|
https://pubmed.ncbi.nlm.nih.gov/40415446/ Biliary atresia J Pediatr Gastroenterol Nutr. 2025 May 25. Splenic-Z-score predicts severe portal hypertensive changes on colonoscopy in infants and children with biliary atresia Vipul Gautam 1, Rajeev Khanna 1, Vikrant Sood 1, Bikrant Bihari Lal 1, Shalini Thapar Laroia 2, Vikram Bhatia 3, Seema Alam 1 DOI: 10.1002/jpn3.70079 Published on:
May-2025
|
https://pubmed.ncbi.nlm.nih.gov/40380181/ NAFLD BMC Pediatr. 2025 May 16;25(1):390. Applicability of multiple quantitative ultrasound liver biomarkers in children and adolescents with severe obesity Ivan Cetinic 1 2, Charlotte de Lange 3 4, Kerstin Lagerstrand 5 6, Jenny M Kindblom 7 8 9, Lovisa Sjögren 7 9, Hanna Hebelka 3 4 PMCID: PMC12083147 DOI: 10.1186/s12887-025-05750-1 Abstract Published on:
May-2025
|
|
https://pubmed.ncbi.nlm.nih.gov/40389840/ Cholestasis BMC Pediatr. 2025 May 19;25(1):404. Biliary obstruction in pediatric hereditary spherocytosis: a clinical review of 16 cases Xinjie Huang 1, Chunhui Peng 2, Yajun Chen 1, Dongyang Wu 1, Wei Chen 1 3, Zengmeng Wang 1, Kai Wang 1 Abstract Background: Biliary obstruction is a rare complication in patients with hereditary spherocytosis (HS). The clinical course and optimal treatment strategies for HS patients complicated by biliary obstruction remain unclear. Published on:
May-2025
|
https://pubmed.ncbi.nlm.nih.gov/40374485/ Cholestasis Arab J Gastroenterol. 2025 May 14:S1687-1979(24)00133-3. Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis Lin Jiang 1, Qiuyu Jiang 2, Can Yang 2 DOI: 10.1016/j.ajg.2024.12.005 Abstract Background and study aims: The aim of this study was to explore and evaluate the clinical effect of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal cholestasis. Published on:
May-2025
|
|
https://pubmed.ncbi.nlm.nih.gov/40384511/ Liver Transplant J Pediatr Gastroenterol Nutr. 2025 May 19. Sirolimus utilization in pediatric liver transplantation: A large high-volume quaternary center experience Wenly Ruan 1 2, Dana N Cerminara 3, Nhu Thao Nguyen Galvan 4 5, Douglas S Fishman 1 2, Sanjiv Harpavat 1 2, Paula M Hertel 1 2, Krupa R Mysore 1 2, Mary Elizabeth Tessier 1 2, Kelby Fuller 4 5, Marielle Faraone 4 5, Ronald T Cotton 4 5, Christine A O'Mahony 4 5, Abbas Rana 4 5, John A Goss 4 5, Daniel H Leung 1 2 DOI: 10.1002/jpn3.70073 Abstract Published on:
May-2025
|
https://pubmed.ncbi.nlm.nih.gov/40447135/ Biliary atresia J Pediatr. 2025 May 28:114673. General and Autism-Related Neurodevelopmental Difficulties in Biliary Atresia M Earl 1, M Samyn 2, C Blackmore 3, M Brace 3, J Day 2, A Javed 3, J Begum-Ali 4, M H Johnson 4, E J H Jones 4, A Dhawan 2, G M McAlonan 3 DOI: 10.1016/j.jpeds.2025.114673 Full text linksCite Published on:
May-2025
|
|
https://pubmed.ncbi.nlm.nih.gov/40369763/ MASLD Clin Exp Pediatr. 2025 May 12. Metabolic dysfunction-associated steatotic liver disease in children: a practical update based on Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) 2024 guidelines Ankit Agrawal 1, Arghya Samanta 2 DOI: 10.3345/cep.2025.00157 Published on:
May-2025
|
https://pubmed.ncbi.nlm.nih.gov/40301849/ Metabolic BMC Pediatr. 2025 Apr 29;25(1):337. Gut microbiome dysbiosis as a potential biomarker for liver metabolic disorders in in neonatal hemolytic jaundice Jin Huang # 1 2, Bi Zhou # 2, Feng Zhu 2, Ying Li 2, Yingying Li 2, Rui Zhang 2, Jingling Zhang 2, Lili Wang 3 PMCID: PMC12039124 DOI: 10.1186/s12887-025-05692-8 Abstract Background: This study aims to reveal the composition and features of the gut microbiota in neonatal hemolytic jaundice, potentially identifying biomarkers for the diagnosis of this condition. Published on:
Apr-2025
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
